Human Stem Cell-Derived Extracellular Vesicles: A Pioneering Path from Biogenesis to Cerebral Ischemic Stroke Therapy
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262110550 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Anamika Roy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Florida State University, Tallahassee, FL 32310, USA. Hauptthemen laut MEDLINE: Extracellular Vesicles, Ischemic Stroke, Stem Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 182 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institutes of Health, National Science Foundation.
Themen: Schlaganfall
Abstract (Originalsprache)
Despite advances in modern medicine and increased public awareness, cerebral stroke remains a leading cause of death and long-term disability worldwide. With over 600,000 new cases annually, innovative therapeutic strategies are being explored to enhance recovery outcomes. One promising approach is the use of human stem cell-derived extracellular vesicles (EVs), particularly exosomes, which function as mediators of intercellular communication. EVs have emerged as pivotal mediators of intercellular communication with immense potential in therapeutic applications. This review discusses the pioneering journey of EVs from their biogenesis and molecular cargo loading to their translation into clinical strategies for cerebral ischemic stroke therapy. While direct stem cell transplantation has faced limitations such as immune rejection, tumorigenicity, and short shelf life, human stem cell-derived EVs offer a cell-free alternative with enhanced safety, stability, and functional versatility. Preclinical studies reveal their capacity to modulate inflammation, protect neural tissue, and promote recovery through the transfer of bioactive molecules. Additionally, EVs isolated from biofluids such as blood and cerebrospinal fluid serve as promising biomarkers for stroke severity and prognosis. Despite this promise, several challenges persist—from standardizing isolation techniques and optimizing therapeutic cargo to scaling up production for clinical-grade use. This review critically examines the current understanding of EV biology, highlights the advances in stroke-related applications, and outlines key hurdles that must be addressed to unlock their full therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Florida State University, Tallahassee, FL 32310, USA.
- National High Magnetic Field Laboratory, Florida State University, Tallahassee, FL 32310, USA.
ORCID-Profile: Samuel C Grant, Yan Li
Förderung
- NINDS NIH HHS
- National Institutes of Health
- National Science Foundation
- National High Magnetic Field Laboratory
Zitieren
APA
Roy, A., Driscoll, T., Grant, S. C., & Li, Y. (2025). Human Stem Cell-Derived Extracellular Vesicles: A Pioneering Path from Biogenesis to Cerebral Ischemic Stroke Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110550
Vancouver
Roy A, Driscoll T, Grant SC, Li Y. Human Stem Cell-Derived Extracellular Vesicles: A Pioneering Path from Biogenesis to Cerebral Ischemic Stroke Therapy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110550
BibTeX
@article{Roy2025,
author = {Roy, Anamika and Driscoll, Tristan and Grant, Samuel C and Li, Yan},
title = {Human Stem Cell-Derived Extracellular Vesicles: A Pioneering Path from Biogenesis to Cerebral Ischemic Stroke Therapy},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262110550}
}
EUVIMED